SKI Market

A+| A| A-|

Indian Indices

Sensex

73,832.55 -150.63
( -0.20%)

Global Indices

Nasdaq

49,934.70 -958.41
(-1.88%)

Dow Jones

7,287.94 -119.71
(-1.62%)

Hang Seng

64,050.08 -129.19
(-0.20%)

Nikkei 225

10,316.43 61.62
(0.60%)

Forex

USD-INR

95.41 -0.12
(-0.12%)

EUR-INR

110.18 0.04
(0.03%)

GBP-INR

127.60 0.17
(0.13%)

JPY-INR

0.60 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Laurus Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540222

INE947Q01028

97.214696

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LAURUSLABS

100.66

74827.27

EPS(TTM)

Face Value()

Div & Yield %

13.76

0.14

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	6089.07	5216.98	4812.39	5773.45	4707.04	4768.72
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	6089.07	5216.98	4812.39	5773.45	4707.04	4768.72
Other Income	77.43	100.47	47.42	15.95	21.55	27.32
Stock Adjustments	236.87	13.55	102.48	-40.82	218.62	296.45
Total Income	6403.37	5331.00	4962.29	5748.58	4947.21	5092.49
EXPENDITURE :
Raw Materials	2797.49	2476.74	2507.87	2671.65	2427.18	2471.58
Power & Fuel Cost	330.61	289.49	309.67	301.10	188.52	149.69
Employee Cost	683.52	570.78	531.93	477.88	417.57	364.83
Other Manufacturing Expenses	585.95	482.35	491.94	431.99	326.34	298.12
Selling & Administrative Expenses	393.76	393.12	293.96	323.95	265.52	260.60
Miscellaneous Expenses	96.35	73.72	29.62	44.30	15.33	10.48
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	4887.68	4286.20	4164.99	4250.87	3640.46	3555.30
Operating Profit	1515.69	1044.80	797.30	1497.71	1306.75	1537.19
Interest	142.96	182.20	150.82	145.70	95.86	65.92
Gross Profit	1372.73	862.60	646.48	1352.01	1210.89	1471.27
Depreciation	378.64	358.79	345.01	300.58	235.48	196.64
Profit Before Tax	994.09	503.81	301.47	1051.43	975.41	1274.63
Tax	285.12	153.84	87.94	270.78	231.42	334.98
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-31.51	-30.42	-10.17	20.27	-6.10	-16.46
Reported Net Profit	740.48	380.39	223.70	760.38	750.09	956.11
Extraordinary Items	-3.17	75.87	-0.57	-0.14	-0.85	-0.63
Adjusted Net Profit	743.65	304.52	224.27	760.52	750.94	956.74
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	3704.87	3367.61	3230.09	2577.18	1912.95	1031.88
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	86.33	43.13	86.18	107.47	85.86	75.04
P & L Balance carried down	4359.02	3704.87	3367.61	3230.09	2577.18	1912.95
Dividend	86.33	43.13	86.18	107.47	85.86	75.04
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	100.00	60.00	40.00	100.00	100.00	100.00
Dividend Per Share(Rs)	2.00	1.20	0.80	2.00	2.00	2.00
Earnings Per Share-Unit Curr	13.72	7.05	4.15	14.12	13.96	17.82
Earnings Per Share(Adj)-Unit Curr	13.72	7.05	4.15	14.12	13.96	17.82
Book Value-Unit Curr	97.29	84.64	78.06	75.31	63.05	50.54
Book Value(Adj)-Unit Curr	97.29	84.64	78.06	75.31	63.05	50.54

73,832.55 -150.63 ( -0.20%)

49,934.70 -958.41 (-1.88%)

7,287.94 -119.71 (-1.62%)

64,050.08 -129.19 (-0.20%)

10,316.43 61.62 (0.60%)

95.41 -0.12 (-0.12%)

110.18 0.04 (0.03%)

127.60 0.17 (0.13%)

0.60 0.00 (-0.17%)